• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾病综合征且白蛋白水平相对较高患者的血栓栓塞事件风险:一项超过 10 年的研究。

The risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels: a study over 10 years.

机构信息

Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.

Key Laboratory of Renal Disease, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Ministry of Health of China, Beijing, China.

出版信息

BMC Nephrol. 2024 Sep 11;25(1):301. doi: 10.1186/s12882-024-03704-w.

DOI:10.1186/s12882-024-03704-w
PMID:39261806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11389433/
Abstract

BACKGROUND

Low albumin level is a risk factor for thromboembolic events in patients with NS (nephrotic syndrome). However, little is known about the proportion and characteristics of patients with NS who experience thromboembolic events with relatively high albumin levels (≥ 25 g/L). Therefore, we explored the features of this specific group of patients.

METHODS

This study included all hospitalized patients in our center for the past 10 years who had diagnoses of NS and relevant thromboembolic events. We divided them into 2 groups based on their serum albumin level when the thromboembolic event occurred. The clinical data were analyzed with SPSS software.

RESULTS

There were 312 patients enrolled in our study. Eighty-four (26.9%) of them had relatively high albumin levels (≥ 25 g/L). Patients with NS with high albumin levels had significantly lower levels of 24-h proteinuria (P < 0.01) and a higher rate of autoimmune disease (P = 0.03) than the low-albumin group. Membranous nephropathy (MN) was the most frequent pathological type of NS in patients with thromboembolic events, regardless of their albumin level. There were significantly fewer patients with anti-PLA2R (M-type phospholipase A2 receptor)-positive MN in the high-albumin group than in the low-albumin group (P < 0.01).

CONCLUSIONS

Our study found that there was still a high risk for patients with NS and relatively high albumin levels to develop thromboembolic events.

摘要

背景

低白蛋白血症是肾病综合征(NS)患者发生血栓栓塞事件的危险因素。然而,对于白蛋白水平相对较高(≥25g/L)的 NS 患者发生血栓栓塞事件的比例和特征知之甚少。因此,我们探讨了这一特定人群的特征。

方法

本研究纳入了过去 10 年来在我院住院的所有诊断为 NS 且发生过相关血栓栓塞事件的患者。我们根据血栓栓塞事件发生时的血清白蛋白水平将其分为 2 组。采用 SPSS 软件对临床资料进行分析。

结果

本研究共纳入 312 例患者,其中 84 例(26.9%)白蛋白水平相对较高(≥25g/L)。与低白蛋白组相比,高白蛋白组 NS 患者的 24 小时尿蛋白定量显著降低(P<0.01),自身免疫性疾病的发生率更高(P=0.03)。膜性肾病(MN)是血栓栓塞事件患者中最常见的 NS 病理类型,无论其白蛋白水平如何。高白蛋白组抗 PLA2R(M 型磷脂酶 A2 受体)阳性 MN 患者明显少于低白蛋白组(P<0.01)。

结论

本研究发现,白蛋白水平相对较高的 NS 患者仍存在发生血栓栓塞事件的高风险。

相似文献

1
The risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels: a study over 10 years.肾病综合征且白蛋白水平相对较高患者的血栓栓塞事件风险:一项超过 10 年的研究。
BMC Nephrol. 2024 Sep 11;25(1):301. doi: 10.1186/s12882-024-03704-w.
2
Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome.一大群肾病综合征患者血清白蛋白水平与静脉血栓栓塞事件的关联
Nephrol Dial Transplant. 2017 Jan 1;32(1):157-164. doi: 10.1093/ndt/gfw227.
3
Serum PLA2R antibody as a predictive biomarker for venous thromboembolism risk in primary membranous nephropathy.血清 PLA2R 抗体作为原发性膜性肾病静脉血栓栓塞风险的预测生物标志物。
Med Clin (Barc). 2023 Nov 24;161(10):417-421. doi: 10.1016/j.medcli.2023.06.007. Epub 2023 Jul 31.
4
Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome.纤维蛋白原-白蛋白比值预测伴有肾病综合征的磷脂酶 A2 受体相关膜性肾病的治疗反应。
Ren Fail. 2024 Dec;46(1):2359024. doi: 10.1080/0886022X.2024.2359024. Epub 2024 Jun 4.
5
[Thromboembolic complications in nephrotic syndrome].[肾病综合征中的血栓栓塞并发症]
Dtsch Med Wochenschr. 2013 May;138(21):1123-9. doi: 10.1055/s-0033-1343113. Epub 2013 May 15.
6
The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study.IgA 肾病中肾病综合征与肾病范围蛋白尿患者的差异:一项倾向评分匹配队列研究。
BMC Nephrol. 2022 Apr 29;23(1):163. doi: 10.1186/s12882-022-02799-3.
7
High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.肾病综合征患者静脉和动脉血栓栓塞事件的高绝对风险及预测因素:一项大型回顾性队列研究的结果
Circulation. 2008 Jan 15;117(2):224-30. doi: 10.1161/CIRCULATIONAHA.107.716951. Epub 2007 Dec 24.
8
[Complications of nephrotic syndrome with special reference to thromboembolic accidents].[肾病综合征的并发症,特别提及血栓栓塞性意外]
Schweiz Med Wochenschr. 1979 Feb 10;109(6):200-9.
9
Antithrombin III level in children with nephrotic syndrome, its correlation to thromboembolic complications, and serum albumin level.肾病综合征患儿抗凝血酶 III 水平及其与血栓栓塞并发症和血清白蛋白水平的相关性。
Saudi J Kidney Dis Transpl. 2021 Sep-Oct;32(5):1283-1288. doi: 10.4103/1319-2442.344747.
10
Hemostatic problems and thromboembolic complications in nephrotic children.肾病患儿的止血问题和血栓栓塞并发症
Pediatr Nephrol. 2000 Feb;14(2):138-42. doi: 10.1007/s004670050029.

引用本文的文献

1
Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants.肾病综合征中的静脉血栓栓塞预防:阿司匹林、维生素K拮抗剂及直接口服抗凝剂的作用
Kidney Int Rep. 2025 Feb 21;10(5):1335-1345. doi: 10.1016/j.ekir.2025.02.010. eCollection 2025 May.

本文引用的文献

1
Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy.ELISA 检测的抗 PLA2R 抗体可预测原发性膜性肾病患者静脉血栓形成的风险。
Ren Fail. 2022 Dec;44(1):594-600. doi: 10.1080/0886022X.2022.2057861.
2
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.膜性肾病患者的 Th17 免疫反应与血栓形成和复发有关。
Front Immunol. 2020 Nov 26;11:574997. doi: 10.3389/fimmu.2020.574997. eCollection 2020.
3
Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications.肾病综合征的预防性抗凝可预防血栓栓塞并发症。
BMC Nephrol. 2019 Apr 25;20(1):139. doi: 10.1186/s12882-019-1336-8.
4
Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome.直接作用口服抗凝剂用于预防肾病综合征中的血栓栓塞
Kidney Int Rep. 2018 Mar 3;3(4):784-793. doi: 10.1016/j.ekir.2018.02.010. eCollection 2018 Jul.
5
Renal Involvement in Antiphospholipid Syndrome.抗磷脂综合征的肾脏受累。
Front Immunol. 2018 May 17;9:1008. doi: 10.3389/fimmu.2018.01008. eCollection 2018.
6
Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome.一大群肾病综合征患者血清白蛋白水平与静脉血栓栓塞事件的关联
Nephrol Dial Transplant. 2017 Jan 1;32(1):157-164. doi: 10.1093/ndt/gfw227.
7
Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.中国膜性肾病患者中的抗磷脂酶A2受体抗体
Med Sci Monit. 2016 May 15;22:1630-6. doi: 10.12659/msm.896090.
8
Patients with primary membranous nephropathy are at high risk of cardiovascular events.原发性膜性肾病患者发生心血管事件的风险很高。
Kidney Int. 2016 May;89(5):1111-1118. doi: 10.1016/j.kint.2015.12.041. Epub 2016 Feb 26.
9
Acute jugular vein thrombosis during rituximab administration: Review of the literature.利妥昔单抗给药期间的急性颈静脉血栓形成:文献综述
J Oncol Pharm Pract. 2016 Feb;22(1):165-9. doi: 10.1177/1078155214543278. Epub 2014 Jul 24.
10
Renal involvement in antiphospholipid syndrome.抗磷脂综合征的肾脏受累。
Nat Rev Nephrol. 2014 May;10(5):279-89. doi: 10.1038/nrneph.2014.38. Epub 2014 Mar 18.